Targeting Neglected Diseases Tuesday, August 16, 2016 New enzyme-mapping advance could help drug development. Calorimetry and Collaboration Tuesday, August 16, 2016 Leading microcalorimetry experts from across the globe will be joining Malvern MicroCal scientists at open forum meetings in Europe and the USA that provide a valuable opportunity for scientists to extend their understanding and application of this powerful analytical technique. A New Method Simplifies Blood Biomarker Discovery And Analysis Tuesday, August 16, 2016 Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Protagen, Inova Announce Agreement for BICD2 Biomarker Friday, August 12, 2016 The license agreement will allow Inova to add the novel biomarker to their portfolio of CTD reagents to help improve diagnosis of this debilitating disease.The Genetics Behind Anxiety Disorders Friday, August 12, 2016 Anxiety disorders are the most common type of mental illness in the United States. And while much is understood about the biochemistry of anxiety, little is known about the genetic variation associated with it.Metabolon Closes $15M Financing Round Friday, August 12, 2016 Metabolon has announced that it has closed a financing that raised $15 million from new investor Essex Woodlands, a leading healthcare growth equity firm. How Cloud Connectivity Can Combat the Reproducibility Crisis Friday, August 12, 2016 This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.Gilead, Polyphor Partner to Discover Macrocycle Drugs Thursday, August 11, 2016 Polyphor Ltd has announced the signing of a collaboration and license agreement with Gilead Sciences Inc., Foster City, California, USA. Using Big Data to Discover Potential Cancer Biomarkers Thursday, August 11, 2016 University of Hawai'i Cancer Center researchers used "Big Data" to discover potential cancer biomarkers, a panel of six long intergenic non-coding RNAs (lincRNAs), for the diagnosis of all types of cancers including lung, breast, prostate, liver and ovarian cancers.